Literature DB >> 9813620

Formation of hydrated calcium oxalates in the presence of poly-L-aspartic acid.

J A Wesson1, E Worcester.   

Abstract

The effect of poly-L-aspartic acid (PA) on the crystal structure of calcium oxalate crystals grown after spontaneous nucleation was evaluated as a function of relative supersaturation and calcium:oxalate ratio in a buffered salt solution, with pH and ionic strength in the range of normal human urine. PA was used as a model for naturally occurring acidic urine proteins that have been shown to inhibit nucleation and growth of calcium oxalate crystals. The crystals grown were characterized by optical microscopy and X-ray powder diffraction. It was observed that calcium oxalate monohydrate was the preferred crystalline form in the absence of added PA, and it was the only crystalline form obtained at most conditions tested without PA. However, the presence of PA favored the formation of calcium oxalate dihydrate crystals, when present in adequate quantities. The quantity of PA required to affect this change in preferred crystal structure was increased at higher supersaturations and at lower calcium:oxalate ratios, exhibiting a non-linear dependence on both variables. PA was also shown to be a kinetic inhibitor of calcium oxalate dihydrate crystallization. Aspartic acid monomer was found to cause no change in the preferred structure of calcium oxalate monohydrate at mass concentrations well beyond those required with PA to obtain 100% calcium oxalate dihydrate, indicating the critical importance of the polymeric nature of PA for this effect on crystal structure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9813620

Source DB:  PubMed          Journal:  Scanning Microsc        ISSN: 0891-7035


  8 in total

1.  A comparison of the binding of urinary calcium oxalate monohydrate and dihydrate crystals to human kidney cells in urine.

Authors:  Tingting Wang; Lauren A Thurgood; Phulwinder K Grover; Rosemary L Ryall
Journal:  BJU Int       Date:  2010-12       Impact factor: 5.588

2.  Face-specific incorporation of osteopontin into urinary and inorganic calcium oxalate monohydrate and dihydrate crystals.

Authors:  Lauren A Thurgood; Alison F Cook; Esben S Sørensen; Rosemary L Ryall
Journal:  Urol Res       Date:  2010-07-22

3.  Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease.

Authors:  Maurizio Bruschi; Simona Granata; Laura Santucci; Giovanni Candiano; Antonia Fabris; Nadia Antonucci; Andrea Petretto; Martina Bartolucci; Genny Del Zotto; Francesca Antonini; Gian Marco Ghiggeri; Antonio Lupo; Giovanni Gambaro; Gianluigi Zaza
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-24       Impact factor: 8.237

4.  Proteolysis and partial dissolution of calcium oxalate: a comparative, morphological study of urinary crystals from black and white subjects.

Authors:  Dawn Webber; Magali C Chauvet; Rosemary L Ryall
Journal:  Urol Res       Date:  2005-05-05

Review 5.  The role of macromolecules in the formation of kidney stones.

Authors:  Jeffrey D Rimer; Ann M Kolbach-Mandel; Michael D Ward; Jeffrey A Wesson
Journal:  Urolithiasis       Date:  2016-12-02       Impact factor: 3.436

6.  Acidic polyanion poly(acrylic acid) prevents calcium oxalate crystal deposition.

Authors:  Jack G Kleinman; Laura J Alatalo; Ann M Beshensky; Jeffrey A Wesson
Journal:  Kidney Int       Date:  2008-06-18       Impact factor: 10.612

7.  Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning.

Authors:  Yung-Ching Chien; David L Masica; Jeffrey J Gray; Sarah Nguyen; Hojatollah Vali; Marc D McKee
Journal:  J Biol Chem       Date:  2009-07-06       Impact factor: 5.157

8.  Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease.

Authors:  Maurizio Bruschi; Simona Granata; Giovanni Candiano; Antonia Fabris; Andrea Petretto; Gian Marco Ghiggeri; Giovanni Gambaro; Gianluigi Zaza
Journal:  Int J Mol Sci       Date:  2019-11-05       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.